Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optic Neuropathy, Anterior Ischemic”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableStudy completedNCT06031350
What this trial is testing

Peripapillary and Macular Vascular Changes of Unilateral Anterior Ischemic Optic Neuropathy: An Optical Coherence Tomography Angiography Study

Who this might be right for
Non-arteritic Ischemic Optic Neuropathy
Omar Said 30
Testing effectiveness (Phase 2)UnknownNCT03173638
What this trial is testing

Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy

Who this might be right for
Non Arteritic Ischemic Optic Neuropathy
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 5
Not applicableStudy completedNCT01131104
What this trial is testing

Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors

Who this might be right for
Nonarteritic Anterior Ischemic Optic Neuropathy
Eli Lilly and Company 345
Not applicableStudy completedNCT00140491
What this trial is testing

Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy

Who this might be right for
Non-Arteritic Anterior Ischemic Optic Neuropathy
Emory University 20
Post-approval studies (Phase 4)Ended earlyNCT00867815
What this trial is testing

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Anterior Ischemic Optic Neuropathy
Bayer 10
Large-scale testing (Phase 3)Ended earlyNCT02341560
What this trial is testing

Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Non Arteritic Anterior Ischemic Optic Neuropathy
Quark Pharmaceuticals 732
Testing effectiveness (Phase 2)UnknownNCT03851562
What this trial is testing

Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy

Who this might be right for
Ischemic Optic Neuropathy
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 24
Testing effectiveness (Phase 2)UnknownNCT03715881
What this trial is testing

NAION Treatment With Oral Prednisolone and Erythropoietin Injection

Who this might be right for
Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Shahid Beheshti University of Medical Sciences 99
Not applicableStudy completedNCT07330713
What this trial is testing

Platelet-Rich Plasma for Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Prospective Randomized Controlled Study

Who this might be right for
Nonarteritic Anterior Ischemic Optic Neuropathy
Uludag University 31
Not applicableStudy completedNCT02019927
What this trial is testing

Electric Stimulation of the Eye to Improve Vision After Trauma

Who this might be right for
Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)TraumaMultiple Sclerosis (MS)
Wills Eye 97
Testing effectiveness (Phase 2)UnknownNCT04239196
What this trial is testing

Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA

Who this might be right for
Giant Cell ArteritisOptic Ischaemic Neuropathy
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 58
Not applicableUnknownNCT01768260
What this trial is testing

Effect of EECP on Anterior Ischemic Optic Neuropathy

Who this might be right for
Anterior Ischemic Optic Neuropathy
First Affiliated Hospital, Sun Yat-Sen University 40
Not applicableLooking for participantsNCT06500728
What this trial is testing

Visual Involvement in Giant Cell Arteritis

Who this might be right for
Giant Cell ArteritisVisual ImpairmentCentral Retinal Artery Occlusion+6 more
ASST Fatebenefratelli Sacco 762
Testing effectiveness (Phase 2)UnknownNCT00813059
What this trial is testing

Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy

Who this might be right for
Non-arteritic Anterior Ischemic Optic Neuropathy
Mount Sinai Hospital, Canada 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07453888
What this trial is testing

Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Non-Arteritic Anterior Ischemic Optic Neuropathy
Dompé Farmaceutici S.p.A 272
Early research (Phase 1)UnknownNCT02394613
What this trial is testing

A Phase I Clinical Trial of DARC

Who this might be right for
GlaucomaOcular HypertensionGlaucoma, Suspect
University College, London 16
Post-approval studies (Phase 4)Study completedNCT01975324
What this trial is testing

A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Non Arteritic Ischemic Optic Neuropathy
Neuro-Ophthalmologic Associates, PC 20
Early research (Phase 1)WithdrawnNCT01607671
What this trial is testing

Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%

Who this might be right for
Optic Neuropathy, IschemicAnterior Ischemic Optic NeuropathyIschemic Optic Neuropathy+1 more
Fraser Health
Large-scale testing (Phase 3)UnknownNCT02329288
What this trial is testing

Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION

Who this might be right for
Triamcinolone AcetonideOptic Neuropathy, Ischemic
Second Military Medical University 60
Early research (Phase 1)Study completedNCT01064505
What this trial is testing

Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients

Who this might be right for
Optic AtrophyNon-arteritic Anterior Ischemic Optic Neuropathy
Quark Pharmaceuticals 48
Load More Results